Contemporary issues in refractory dyspnoea in advanced chronic obstructive pulmonary disease
1Division of Palliative Medicine, Canada bDivision of Respirology, QEII Health Science Centre and Dalhousie University, Halifax, Nova Scotia, Canada.
Purpose Of Review:
Relieving dyspnoea when chronic obstructive pulmonary disease (COPD) no longer responds to disease-modifying therapy is challenging, with limited evidence to provide guidance. This review highlights recent advances that further our understanding and management of refractory dyspnoea in COPD, focusing on interventions that are considered beyond the conventional treatment of airflow obstruction/hyperinflation.
Recent Findings:
Advances in functional brain imaging have improved our understanding of limbic system activation in dyspnoea, providing insight into potential for targeted treatments. Qualitative research is defining the complexities of the multidimensional aspects of dyspnoea, supporting the need to address dyspnoea-related affective distress in prospective outcomes-based research. Studies evaluating inhaled furosemide in exertional dyspnoea and palliative noninvasive ventilation in advanced disease support ongoing work in this area. In addition, recent advances in delivery of rapidly acting opioids offer intriguing potential for management of incidental dyspnoea in advanced disease.
Summary:
Improved understanding of the nature of dyspnoea in advanced COPD, advances in symptom mapping and noninvasive ventilatory support along with the potential of novel treatments offer hope that we can improve the management of refractory dyspnoea in COPD. Where evidence is lacking, we outline options that merit further evaluation.
More Related Videos
05:34Auricular Acupuncture as a Traditional Chinese Medicine Therapy for Chronic Obstructive Pulmonary Disease Combined with Sleep Disorders
Published on: August 18, 2023
04:03Alternative Therapy for Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Moving Cupping Along Meridians
Published on: September 27, 2024
Related Concept Videos
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
COPD: Management Using Bronchodilators and Corticosteroids
Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations
Chronic Obstructive Pulmonary Disease-I: Introduction
